Search

Daniel M. Sullivan

Director (ID: 12309, Phone: (571)272-0900 , Office: P/1600 )

Most Active Art Unit
1636
Art Unit(s)
1600, 1611, 1621, 1636
Total Applications
646
Issued Applications
156
Pending Applications
192
Abandoned Applications
334

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18055638 [patent_doc_number] => 20220386724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => ANTIMICROBIAL DYES FOR HEALTHCARE APPAREL [patent_app_type] => utility [patent_app_number] => 17/624154 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624154 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/624154
ANTIMICROBIAL DYES FOR HEALTHCARE APPAREL Jun 30, 2020 Abandoned
Array ( [id] => 18065687 [patent_doc_number] => 20220396774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => COMPOSITIONS AND METHODS FOR GENERATING INSULIN-PRODUCING BETA CELLS [patent_app_type] => utility [patent_app_number] => 17/622436 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16053 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622436 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/622436
COMPOSITIONS AND METHODS FOR GENERATING INSULIN-PRODUCING BETA CELLS Jun 30, 2020 Pending
Array ( [id] => 18707581 [patent_doc_number] => 20230330158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE [patent_app_type] => utility [patent_app_number] => 17/915610 [patent_app_country] => US [patent_app_date] => 2020-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915610 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915610
INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE Jun 23, 2020 Abandoned
Array ( [id] => 17808721 [patent_doc_number] => 20220260556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => SALIVA TESTING [patent_app_type] => utility [patent_app_number] => 17/624333 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/624333
SALIVA TESTING Jun 22, 2020 Abandoned
Array ( [id] => 18226820 [patent_doc_number] => 20230065814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/596831 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34186 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 700 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596831 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/596831
CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS Jun 18, 2020 Pending
Array ( [id] => 17895467 [patent_doc_number] => 20220305129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => CONJUGATES OF HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/596833 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17019 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 315 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596833 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/596833
CONJUGATES OF HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS Jun 18, 2020 Pending
Array ( [id] => 17805715 [patent_doc_number] => 20220257550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR DHA [patent_app_type] => utility [patent_app_number] => 17/625295 [patent_app_country] => US [patent_app_date] => 2020-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625295 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625295
REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR DHA Jun 15, 2020 Abandoned
Array ( [id] => 17895395 [patent_doc_number] => 20220305057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => METHODS OF MAKING CELLULAR PRODUCTS BY POST- MORTEM MOBILIZATION AND HARVESTING OF HEMATOPOIETIC CELLS [patent_app_type] => utility [patent_app_number] => 17/616869 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17616869 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/616869
METHODS OF MAKING CELLULAR PRODUCTS BY POST- MORTEM MOBILIZATION AND HARVESTING OF HEMATOPOIETIC CELLS Jun 1, 2020 Abandoned
Array ( [id] => 17760014 [patent_doc_number] => 20220233626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => GRAPE PERICARP EXTRACT [patent_app_type] => utility [patent_app_number] => 17/595842 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595842 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595842
GRAPE PERICARP EXTRACT May 21, 2020 Abandoned
Array ( [id] => 17748000 [patent_doc_number] => 20220226203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => SKIN-ATTACHABLE THIN FILM PATCH BASED ON A WATER-SOLUBLE NON-WOVEN FABRIC [patent_app_type] => utility [patent_app_number] => 17/612937 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2352 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612937 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612937
SKIN-ATTACHABLE THIN FILM PATCH BASED ON A WATER-SOLUBLE NON-WOVEN FABRIC May 20, 2020 Abandoned
Array ( [id] => 17718976 [patent_doc_number] => 20220211695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => MORPHINE-INDUCED RESPIRATORY DEPRESSION: BEHAVIORAL, PHRENIC AND BRAINSTEM RESPIRATORY NEURONAL EVIDENCE [patent_app_type] => utility [patent_app_number] => 17/612152 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612152 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612152
MORPHINE-INDUCED RESPIRATORY DEPRESSION: BEHAVIORAL, PHRENIC AND BRAINSTEM RESPIRATORY NEURONAL EVIDENCE May 17, 2020 Abandoned
Array ( [id] => 17705976 [patent_doc_number] => 20220205982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHODS FOR DETERMINING PERSONALIZED FULL DOSE OF MELPHALAN IN REDUCED INTENSITY REGIMEN PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION [patent_app_type] => utility [patent_app_number] => 17/611398 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611398 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/611398
METHODS FOR DETERMINING PERSONALIZED FULL DOSE OF MELPHALAN IN REDUCED INTENSITY REGIMEN PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION May 14, 2020 Abandoned
Array ( [id] => 17719152 [patent_doc_number] => 20220211871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => GENE THERAPIES FOR LYSOSOMAL DISORDERS [patent_app_type] => utility [patent_app_number] => 17/601984 [patent_app_country] => US [patent_app_date] => 2020-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/601984
GENE THERAPIES FOR LYSOSOMAL DISORDERS Apr 9, 2020 Abandoned
Array ( [id] => 17627546 [patent_doc_number] => 20220162561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => COMPOSITION FOR PROMOTING SECRETION OF EXTRACELLULAR VESICLES [patent_app_type] => utility [patent_app_number] => 17/601076 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601076 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/601076
COMPOSITION FOR PROMOTING SECRETION OF EXTRACELLULAR VESICLES Apr 2, 2020 Abandoned
Array ( [id] => 17670995 [patent_doc_number] => 20220184162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/598426 [patent_app_country] => US [patent_app_date] => 2020-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598426 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/598426
PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN TREATING CANCER Mar 26, 2020 Abandoned
Array ( [id] => 17671003 [patent_doc_number] => 20220184170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => FORMULATION TO ENHANCE THE BIOAVAILIBITY AND STABILITY OF CURCUMINOIDS AND/OR ITS DERIVATIVES THEREOF [patent_app_type] => utility [patent_app_number] => 17/437415 [patent_app_country] => US [patent_app_date] => 2020-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437415 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/437415
FORMULATION TO ENHANCE THE BIOAVAILIBITY AND STABILITY OF CURCUMINOIDS AND/OR ITS DERIVATIVES THEREOF Mar 20, 2020 Abandoned
Array ( [id] => 19464223 [patent_doc_number] => 20240317892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => ANTI-ADAM12 ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS COMPRISING [patent_app_type] => utility [patent_app_number] => 17/440299 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440299 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/440299
ANTI-ADAM12 ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS COMPRISING Mar 19, 2020 Pending
Array ( [id] => 17575979 [patent_doc_number] => 20220132834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => METHODS, APPARATUSES, AND SYSTEMS FOR IMPROVING MICROBIAL PRESERVATION YIELD THROUGH RESCUE AND SERIAL PASSAGE OF PRESERVED CELLS [patent_app_type] => utility [patent_app_number] => 17/434529 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27275 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434529 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/434529
METHODS, APPARATUSES, AND SYSTEMS FOR IMPROVING MICROBIAL PRESERVATION YIELD THROUGH RESCUE AND SERIAL PASSAGE OF PRESERVED CELLS Feb 27, 2020 Abandoned
Array ( [id] => 18286360 [patent_doc_number] => 20230101832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => STABLE, LIQUID EMULSIFIERS ON THE BASIS OF CITRATE ESTERS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 17/904639 [patent_app_country] => US [patent_app_date] => 2020-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904639 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904639
STABLE, LIQUID EMULSIFIERS ON THE BASIS OF CITRATE ESTERS AND THEIR USE Feb 24, 2020 Abandoned
Array ( [id] => 17533627 [patent_doc_number] => 20220112236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => IMMUNOGLOBULIN BINDING PROTEINS FOR AFFINITY PURIFICATION [patent_app_type] => utility [patent_app_number] => 17/430238 [patent_app_country] => US [patent_app_date] => 2020-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430238
Immunoglobulin binding proteins for affinity purification Jan 30, 2020 Issued
Menu